Researchers have tapped into the body's own repair system to protect heart cells after an attack. In the study mice were bred to make a supercharged version of the protein focal adhesion kinase, or FAK.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, presented pre-clinical research results at the European Societ... Read Post
Targeting a molecule in blood vessels can make cancer therapy significantly more effective, according to research. Researchers have found that a molecule, called focal adhesion kinase (FAK), signals the body to repair itself after c... Read Post
CHAPEL HILL, N.C. – Researchers from the University of North Carolina at Chapel Hill reduced damage from a heart attack by 50 percent by enhancing a protective protein found in mice and humans. The study, in which mice were bred to ... Read Post